Introducing James Riviello Jr., MD
With great pleasure, we welcome Dr. James Riviello Jr. to our faculty as the Sergievsky Family Professor of Neurology and Pediatrics, director of our Division of Child Neurology, and chief of child neurology at Morgan Stanley Children's Hospital of NewYork-Presbyterian. Dr. Riviello received his undergraduate and medical degrees from Tufts University, completed his pediatrics residency at St. Christopher's Hospital for Children, did neurology and anesthesiology training at Temple University Hospital, and fellowship training in child neurology at St. Christopher's. Over the span of three decades, he has held appointments at several prestigious hospitals and academic institutions. Most recently, Dr. Riviello was director of the pediatric neurology division and professor of neurology and pediatrics at NYU School of Medicine. He is a specialist in pediatric epilepsy and clinical neurophysiology, as well as pediatric critical care neurology. Dr. Riviello has been involved in the production of national and international guidelines for pediatric epilepsy surgery, the diagnostic assessment and treatment of status epilepticus, and continuous EEG monitoring for neonatal seizures. An accomplished clinician, researcher, teacher, and administrator, we are thrilled to have Dr. Riviello join us!
Dr. James Riviello Jr.
For an appointment with Dr. Riviello, please call
US News & World Report 2013 – 2014
NewYork–Presbyterian University Hospital of Columbia and Cornell moved up to #3
in the national Neurology & Neurosurgery
specialty rankings of U.S. News & World Report for 2013–2014!
The NIH rankings are out; Columbia Neurology is ranked #3 in the nation for NIH-funded research.
Introducing Un Jung Kang, MD
Dr. Un Jung Kang
We are thrilled to welcome Dr. Un Jung Kang back to the Department of Neurology as H. Houston Merritt Professor of Neurology and chief of the Division of Movement Disorders. Dr. Kang completed his medical training at Johns Hopkins University and his neurology residency and fellowship in movement disorders here at Columbia, under the mentorship of his legendary predecessor, Dr. Stanley Fahn. Following his clinical education, Dr. Kang obtained his basic science training in catecholamine molecular biology and gene therapy for Parkinson's disease (PD), before joining the faculty of the University of Chicago School of Medicine, where he served as professor of neurology and director of the Parkinson's Disease and Movement Disorders Center. Funded by the National Institutes of Health and private foundations, Dr. Kang's research focuses on the elucidation of mechanisms of long term plasticity of basal ganglia in PD that manifest as either detrimental levodopa-induced dyskinesia or beneficial long duration response to dopaminergic therapy. He plans to translate some of his findings in patient-based studies. Dr. Kang is further interested in developing biomarkers for PD based on basic biological clues, both by leading a biomarker cohort study and developing bioassays in his lab. Dr. Kang is a renowned physician-scientist, an award-winning educator, and a visionary, translational leader. We are thrilled to welcome him back to Columbia Neurology!
For an appointment with Dr. Kang, please call
The NewYork-Presbyterian/Columbia University Medical Center Stroke Center has been awarded the American Heart Association / American Stroke Association Get With The Guidelines® (GWTG) Stroke Gold Plus Performance Achievement Award and Target Stroke.
A GWTG Achievement Award demonstrates the hospital's commitment to quality and ability to work as a team that is dedicated to providing patients with care that is appropriate and based on the latest clinical guidelines with the goal of improving quality patient care and patient outcomes.
Migraine, epilepsy and genetics:
an interview with Dr. Melodie Winawer
[awards & accomplishments] [news]